Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Varlitinib |
| Trade Name | |
| Synonyms | ARRY-334543|ARRY-543 |
| Drug Descriptions |
Varlitinib is a selective inhibitor of EGFR and ERBB2 (HER2), which inhibits downstream signaling, potentially resulting in decreased tumor cell proliferation and increased cell death (PMID: 30658422). |
| DrugClasses | EGFR Inhibitor (Pan) 63 HER2 Inhibitor 44 |
| CAS Registry Number | 845272-21-1 |
| NCIT ID | C62530 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Capecitabine + Varlitinib | Capecitabine Varlitinib | 0 | 1 |
| Trastuzumab + Varlitinib | Trastuzumab Varlitinib | 0 | 0 |
| Varlitinib | Varlitinib | 0 | 0 |